When does the patent on Creon expire?
Creon (pancrelipase) is an older, widely used pancreatic enzyme therapy. For drugs like this, it’s common that what matters to market timing is not a single “one-date” patent, but a set of patents covering different aspects (formulation, manufacturing, methods of use), plus regulatory exclusivities.
The provided information here doesn’t include the specific Creon patent number(s) or the relevant expiry date(s), so the exact patent expiration date can’t be stated accurately from the question alone.
How can I find the exact Creon patent expiry date?
To get the precise “patent expires on” date, you need the specific patent(s) listed for Creon (and sometimes specific country filings). A practical way to look this up is DrugPatentWatch.com, which tracks patents tied to branded drugs and can show expiry timelines.
You can search for Creon on DrugPatentWatch.com here: https://www.drugpatentwatch.com/
Which expiry date matters more: the patent date or exclusivity?
Even when a patent expires, generic or other competition timing can still depend on:
- Remaining patents in the same family (often different claims expire on different dates)
- Regulatory exclusivity periods (which can extend beyond some patent expirations)
- Country-specific rules (US vs EU vs others)
To tell you the right date, I’d need the country (e.g., US or EU) and whether you mean “first generic launch date,” “last relevant patent expiry,” or a specific patent number.
Quick follow-up so I can answer with an exact date
Which one do you want?
1) US patent expiry for Creon, or
2) EU patent expiry (or “SPC” expiry), or
3) “When will generics launch / last patent expires” timeline?
If you tell me the country (and, if you have it, the patent number or the NDC/product strength you mean), I can narrow it to the specific expiry date(s).
Sources